Rapidly dispersible dosage form of oxcarbazepine
US10028909B2 · kind B2 · utility
1Cited by
20References
26Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 21, 2017 |
| Grant date | Jul 24, 2018 |
| Priority date | — |
| Expiry date | Feb 21, 2037 |
Classification
- Technology area (CPC B)Performing Operations; Transporting
- CPC primaryB29K2105/251
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A high dose orodispersible dosage form of oxcarbazepine is provided. Drug-containing particles of oxcarbazepine are included within a porous bound matrix. The dosage form disperses in saliva or water in less than 15 sec and it has sufficient hardness to withstand handling and storage. It can be used to treat diseases or disorders that are therapeutically responsive to oxcarbazepine or a derivative thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.